2. Signaling Pathways
  3. Others
  4. Isotope-Labeled Compounds

Isotope-Labeled Compounds

Isotope-labeled compounds are chemical substances in which some atoms in their molecules are replaced by isotope atoms. The range of stable isotope products can cover from gases to complex molecules. Isotope-labeled compounds could provide a site-specific investigation of structures, making molecules easily detectable by mass spectrometry and NMR, and maintaining the physico-chemical properties of the target molecule at the same time. MCE isotope-labeled compounds are all stable isotope-labeled compounds and are non-radioactive labeled substances. MCE isotope-labeled compounds are unique tools for identifying and understanding biological and chemical processes. Stable isotope-labeled products are now getting more and more popular among scientists. The scope of application is gradually penetrating into various scientific fields, such as life sciences, food and medicine, agriculture, environment, geology, etc. Stable isotope-labeled compounds have a wide range of applications in the Life Science areas, such as Metabolomics, Proteomics, Clinical studies, Deuterium drugs, etc.

Isotope-Labeled Compounds Related Products (7669):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-B0558S
    Carbimazole-d5
    Carbimazole-d5 is deuterium labeled Carbimazole. Carbimazole is an orally active antithyroid agent which rapidly converts to Methimazole after absorption and prevents thyroid peroxidase enzyme from iodinating and coupling the tyrosine residues on thyroglobulin, hence reducing the production of thyroxine. Carbimazole also displays anti-inflammatory and neuronal-protective activities, suggesting its application for hyperthyroidism and neurological research.
    Carbimazole-d<sub>5</sub>
  • HY-113202S
    Stearoyl-L-carnitine-d3
    Stearoyl-L-carnitine-d3 is the deuterium labeled Stearoylcarnitine. Stearoylcarnitine, a fatty ester lipid molecule, is an endogenous metabolite. Stearoylcarnitine can be used as PKC inhibitor. Stearoylcarnitine accumulates in β cells, leading to arrest of insulin synthesis and energy deficiency in type 2 diabetes mouse. Stearoylcarnitine inhibits lecithin cholesterol acyltransferase (LCAT) in rat and rabbits plasma. Stearoylcarnitine acts as a metabolomics biomarker for Parkinson’s disease. Stearoylcarnitine is a less potent inhibitor of GlyT2.
    Stearoyl-L-carnitine-d<sub>3</sub>
  • HY-N9933S
    Tauro-β-muricholic acid-d4-1 sodium
    Tauro-β-muricholic acid-d4-1 (T-βMCA-d4-1) sodium is the deuterium labeled Tauro-β-muricholic acid (HY-N9933).
    Tauro-β-muricholic acid-d<sub>4</sub>-1 sodium
  • HY-113335S1
    Trihydroxycholestanoic acid-d5
    Trihydroxycholestanoic acid-d5 (Coprocholic acid-d5) is deuterium labeled Trihydroxycholestanoic acid. Trihydroxycholestanoic acid is an endogenous metabolite present in Blood that can be used for the research of Zellweger Syndrome, Refsum Disease, D Bifunctional Protein Deficiency and Infantile Refsum Disease.
    Trihydroxycholestanoic acid-d<sub>5</sub>
  • HY-124245S
    3-Hydroxy desloratadine-d4
    3-Hydroxy desloratadine-d4 is the deuterium labeled 3-Hydroxy desloratadine[1].
    3-Hydroxy desloratadine-d<sub>4</sub>
  • HY-12857S2
    Brigatinib-d11
    Brigatinib-d11 (AP-26113-d11) is deuterium labeled Brigatinib. Brigatinib (AP-26113) is a highly potent, selective and orally active ALK inhibitor, with an IC50 of 0.6 nM. Brigatinib can be used for research of NSCLC.
    Brigatinib-d<sub>11</sub>
  • HY-W327895S
    Tris(4-chlorophenyl)methanol-13C19
    Tris(4-chlorophenyl)methanol-13C19 is 13C labeled Tris(4-chlorophenyl)methanol.
    Tris(4-chlorophenyl)methanol-<sup>13</sup>C<sub>19</sub>
  • HY-165682S
    Altenuisol-d3
    Altenuisol-d3 is deuterium labeled Altenuisol.
    Altenuisol-d<sub>3</sub>
  • HY-W741546S
    L-threo-Ritalinic Acid-d5 trifluoroacetate
    L-threo-Ritalinic Acid-d5 (TFA) is deuterium-labeled L-threo-Ritalinic Acid (HY-W741546).
    L-threo-Ritalinic Acid-d<sub>5</sub> trifluoroacetate
  • HY-101491S
    SR-18292-d9
    SR-18292-d9 is the deuterium labeled SR-18292 (HY-101491). SR-18292 is a PPAR gamma coactivator-1α (PGC-1α) inhibitor, which increases PGC-1α acetylation, suppresses gluconeogenic gene expression and reduces glucose production in hepatocytes.
    SR-18292-d<sub>9</sub>
  • HY-131932S
    N-Desethyl-dorzolamide-d3 hydrochloride
    N-Desethyl-dorzolamide-d3 hydrochloride is deuterated labeled N-Desethyl-dorzolamide.
    N-Desethyl-dorzolamide-d<sub>3</sub> hydrochloride
  • HY-W641639S
    2-Cyano-3,3-diphenylacrylic acid-d10
    2-Cyano-3,3-diphenylacrylic acid-d10 is deuterium labeled 2-Cyano-3,3-diphenylacrylic acid.
    2-Cyano-3,3-diphenylacrylic acid-d<sub>10</sub>
  • HY-W654130
    Daunorubicin-13C,d3
    Daunorubicin-13C,d3 is 13C and deuterium labeled Daunorubicin. Daunorubicin (Daunomycin) is a topoisomerase II inhibitor with potent anti-tumor activity. Daunorubicin inhibits DNA and RNA synthesis. Daunorubicin is a cytotoxin that inhibits cancer cell viability and induces apoptosis and necrosis. Daunorubicin is also an anthracycline antibiotic. Daunorubicin can be used in the research of infection and variety of cancers, including leukemia, non-Hodgkin lymphomas, Ewing's sarcoma, Wilms' tumor.
    Daunorubicin-<sup>13</sup>C,d<sub>3</sub>
  • HY-W000854S
    3-Methoxybenzeneboronic acid-d3
    3-Methoxybenzeneboronic acid-d3 is the deuterium labeled 3-Methoxybenzeneboronic acid (HY-W000854). 3-Methoxybenzeneboronic acid is a biochemical reagent that can be used as a biological material or organic compound for life science related research.
    3-Methoxybenzeneboronic acid-d<sub>3</sub>
  • HY-B0419S
    Manidipine-d4
    Manidipine-d4 is the deuterium labeled Manidipine (HY-B0419). Manidipine is an orally active calcium channel antagonist. Manidipine regulates the expression of cytokines (IL-1β, IL-6). Manidipine has a hypotensive effect. Manidipine can be used in the study of cardiovascular diseases (such as hypertension, myocardial ischemia-reperfusion injury, ventricular hypertrophy), kidney diseases (such as glomerular diseases), and epilepsy.
    Manidipine-d<sub>4</sub>
  • HY-125140S
    ω-3 Arachidonic Acid-d8
    ω-3 Arachidonic Acid-d8 is the deuterium labeled ω-3 Arachidonic Acid[1].
    ω-3 Arachidonic Acid-d<sub>8</sub>
  • HY-126042S4
    (±)-Lisofylline-d4
    (±)-Lisofylline-d4 ((±)-Lisophylline-d4) is deuterium labeled (±)-Lisofylline. (±)-Lisofylline ((±)-Lisophylline) is the racemate of Lisofylline. Lisofylline inhibits the generation of phosphatidic acid and free fatty acids. Lisofylline also blocks the release of pro-inflammatory cytokines in oxidative tissue injury, in response to cancer chemotherapy and in experimental sepsis. Lisofylline can be used for Type 1 diabetes research.
    (±)-Lisofylline-d<sub>4</sub>
  • HY-W742416
    3-Mercapto-3-methylbutyl-d6 Formate
    3-Mercapto-3-methylbutyl-d6 Formate is deuterated labeled 3-Mercapto-3-methylbutyl Formate.
    3-Mercapto-3-methylbutyl-d6 Formate
  • HY-W014612S
    Eugenol acetate-d3
    Eugenol acetate-d3 is deuterated labeled Decyl aldehyde (HY-W012570). Decyl aldehyde is a simple ten-carbon aldehyde. Decyl aldehyde is a bacterial luciferase substrate.
    Eugenol acetate-d<sub>3</sub>
  • HY-W744647
    cis-4-Heptenal-D2
    cis-4-Heptenal-d2 is deuterated labeled cis-4-Heptenal.
    cis-4-Heptenal-D2